CSI Market
Sign In | Register

Puma Biotechnology Inc (PBYI) Annual Income Statement

Annual · GAAP · USD millions
Access PBYI quarterly income statements →
The income statement data below highlights shifts in Puma Biotechnology Inc's operating performance over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax228.37
Total Revenue228.37
Costs & Expenses
Cost of Goods and Services Sold58.16
Gross Profit170.21
Selling, Administration, Marketing70.85
Depreciation & Amortization0.00
Research and Development Expense (Excluding Acquired in Process Cost)62.07
Restructuring, Accretion & Impairment Charges0.00
Other Operating Expense / -Income0.00
Total operating costs including COS191.07
Operating income / -loss37.30
Interest Expense0.00
Net Interest Expense / -Income0.00
Extinguishment of Debt0.00
Investment Income, Interest0.00
Other loss / -income-5.11
Total costs & expenses192.59
Income & Taxes
Income / -loss before income taxes35.78
Income taxes expenses / -benefit3.25
Income after income taxes31.11
Net income / -loss of other equity-1.43
Income / -loss from continuing operations31.11
Net income / -loss31.11
Income / -loss to shareholder31.11
EBIT35.78
EBITD46.72
EBITDA46.72
Earnings Per Share
Basic EPS (excl. extra items)0.62
Basic Net EPS0.62
Basic shares outstanding (Mill. of Units)50.01
Diluted Net EPS0.61
Diluted average shares (Mill. of Units)50.65
4 historic quarters locked

Sign in to unlock the full Puma Biotechnology Inc income statement history.

Sign In Create Free Account

About Puma Biotechnology Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.